Is Jardiance (empagliflozin) appropriate for a 75‑year‑old man with hypertension who is already taking three antihypertensive medications?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Jardiance is NOT appropriate as a primary treatment for hypertension in this patient

For a 75-year-old man with hypertension already on three blood pressure medications, Jardiance (empagliflozin) should not be added solely for blood pressure control. While Jardiance does lower blood pressure modestly (3-4 mmHg systolic), it is not a first-line or even second-line antihypertensive agent according to current guidelines.

Why Jardiance is Not the Right Choice Here

Guideline-Based Antihypertensive Therapy

The most recent 2024 ESC guidelines 1 clearly establish that first-line blood pressure-lowering drugs are ACE inhibitors, ARBs, dihydropyridine calcium channel blockers, and thiazide/thiazide-like diuretics—not SGLT2 inhibitors like Jardiance. These four drug classes have the strongest evidence for reducing cardiovascular events and mortality in hypertension.

For a patient already on three medications with uncontrolled blood pressure, the 2024 ESC guidelines 1 recommend:

  • Adding spironolactone (a mineralocorticoid receptor antagonist) as the fourth agent if blood pressure remains uncontrolled on a three-drug combination
  • If spironolactone is not tolerated, consider eplerenone, beta-blockers, alpha-blockers, or centrally acting agents

What You Need to Know First

Before adding any medication, you must determine:

  1. What are the current three medications? The optimal combination should be a RAS blocker (ACE inhibitor or ARB) + calcium channel blocker + thiazide/thiazide-like diuretic 1

  2. Are they at appropriate doses? Many patients are on suboptimal doses

  3. What is the actual blood pressure? Target is 120-129 mmHg systolic if tolerated 1

  4. Is this true resistant hypertension? Rule out:

    • Medication non-adherence (most common cause)
    • White coat hypertension (confirm with home or ambulatory monitoring)
    • Secondary causes of hypertension
    • Excessive sodium intake
    • Excessive alcohol use

When Jardiance WOULD Be Appropriate

Jardiance has compelling indications in specific conditions, but hypertension alone is not one of them:

Strong Indications for Jardiance:

  1. Type 2 diabetes with cardiovascular disease: Jardiance reduced cardiovascular death by 38% (HR 0.62) in the EMPA-REG OUTCOME trial 2

  2. Heart failure with reduced ejection fraction (≤40%): Reduced cardiovascular death or heart failure hospitalization by 25% (HR 0.75) 2

  3. Heart failure with preserved ejection fraction: Reduced cardiovascular death or heart failure hospitalization by 21% (HR 0.79) 2

  4. Chronic kidney disease (eGFR 20-90 mL/min/1.73m² with albuminuria): Reduced kidney disease progression or cardiovascular death by 28% (HR 0.72) 2

The Blood Pressure Effect is Secondary

While Jardiance does lower blood pressure by approximately 3-4 mmHg systolic 3, 4, 5, this effect:

  • Is modest compared to standard antihypertensives
  • Occurs regardless of baseline blood pressure or number of antihypertensive medications 3
  • Is not the primary reason to prescribe it
  • Does not make it appropriate as an antihypertensive agent per guidelines

The Right Approach for This Patient

Step 1: Optimize Current Regimen

  • Ensure the three medications are: RAS blocker + calcium channel blocker + thiazide diuretic at appropriate doses
  • If not, adjust to this combination first 1

Step 2: Add Fourth-Line Agent

  • Spironolactone 25-50 mg daily is the recommended fourth agent for resistant hypertension 1
  • Monitor potassium and creatinine 7-14 days after initiation 6

Step 3: Screen for Compelling Indications

Only add Jardiance if the patient has:

  • Type 2 diabetes (especially with cardiovascular disease or albuminuria)
  • Heart failure (any ejection fraction)
  • Chronic kidney disease with albuminuria

In these scenarios, Jardiance would be added for the compelling indication, with blood pressure reduction as a beneficial side effect—not as the primary therapeutic goal.

Important Caveats

Age Considerations

At 75 years old, this patient requires careful monitoring:

  • The 2024 ESC guidelines 1 note that patients ≥85 years may be exceptions to initial combination therapy
  • However, at 75, standard treatment approaches apply
  • Monitor for orthostatic hypotension when adding medications
  • Ensure blood pressure targets are individualized based on frailty status 7

Safety Monitoring

If Jardiance were added for a compelling indication:

  • Monitor for volume depletion (rare but possible) 2
  • Assess for genital mycotic infections
  • Monitor kidney function
  • Ensure adequate hydration

The bottom line: Jardiance is an excellent medication for specific cardiovascular and renal conditions, but it is not a guideline-recommended treatment for hypertension management. Focus on optimizing standard antihypertensive therapy first, with spironolactone as the appropriate fourth agent if needed 1.

References

Related Questions

What is the appropriate ASA physical status classification for a patient with heart failure with preserved ejection fraction, chronic hypertension, hyperlipidemia, and persistent tachycardia?
Can Jardiance (empagliflozin) help manage pulmonary hypertension?
For a patient taking metformin, empagliflozin (Jardiance), hydrochlorothiazide, nebivolol, and hydralazine, can metformin be reduced to 850 mg twice daily, empagliflozin increased to 25 mg daily, hydrochlorothiazide reduced to 12.5 mg, nebivolol tapered off slowly, and hydralazine increased to three times daily?
Are empagliflozin (Jardiance) and eplerenone appropriate for a patient with preserved left ventricular ejection fraction, mild left‑ventricular chamber enlargement and grade 1 diastolic dysfunction, despite lacking systolic dysfunction?
In a 59-year-old male with diabetes mellitus and hypertension, currently taking metformin 1000 mg twice daily and empagliflozin (Jardiance) 25 mg daily, who has elevated LDL cholesterol, elevated triglycerides, vitamin D deficiency, and an HbA1c of 7.1%, what is the optimal management plan?
Can vortioxetine cause gait disturbances or difficulty walking in elderly patients?
What is Flomax (tamsulosin), and what are its indications, dosing, contraindications, and side effects for treating benign prostatic hyperplasia?
How should chronic interstitial nephritis caused by a remote history of lithium exposure be managed?
What does troponin elevation indicate in stress‑induced cardiomyopathy (Takotsubo syndrome) and how should it be managed?
What is the recommended management for a patient presenting with cough and wheezing, a history of chronic obstructive pulmonary disease (COPD), and who smokes one cigarette per day?
Is kyphoplasty indicated for a ruptured lumbar disc?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.